| Literature DB >> 25671114 |
Liene Bervoets1, Caroline Van Noten2, Sofie Van Roosbroeck3, Dominique Hansen4, Kim Van Hoorenbeeck5, Els Verheyen6, Guido Van Hal3, Vanessa Vankerckhoven6.
Abstract
BACKGROUND: This study was designed to validate the Dutch Physical Activity Questionnaires for Children (PAQ-C) and Adolescents (PAQ-A).Entities:
Keywords: Pediatrics; Physical activity; Reliability; Validation
Year: 2014 PMID: 25671114 PMCID: PMC4323128 DOI: 10.1186/2049-3258-72-47
Source DB: PubMed Journal: Arch Public Health ISSN: 0778-7367
I-CVI and S-CVI scores for the Dutch PAQ-C and PAQ-A
| PAQ-C | |||||||
|---|---|---|---|---|---|---|---|
| Item | Expert 1 | Expert 2 | Expert 3 | Expert 4 | Expert 5 | Expert 6 | I-CVI |
|
| 3 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 3 | 3 | 3 | 3 | 2 | 3 | 0.83 |
|
| 3 | 3 | 3 | 2 | 3 | 2 | 0.67 |
|
| 3 | 3 | 3 | 2 | 3 | 2 | 0.67 |
|
| 4 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 4 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 4 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 3 | 4 | 4 | 3 | 4 | 3 | 1.00 |
|
| 4 | 4 | 4 | 4 | 2 | 4 | 0.83 |
|
|
| ||||||
|
| |||||||
|
|
|
|
|
|
|
|
|
|
| 3 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 3 | 3 | 3 | 3 | 2 | 3 | 0.83 |
|
| NA | NA | NA | NA | NA | NA | NA |
|
| 3 | 3 | 3 | 3 | 2 | 2 | 0.67 |
|
| 4 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 4 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 4 | 4 | 4 | 4 | 4 | 4 | 1.00 |
|
| 2 | 4 | 4 | 3 | 4 | 3 | 0.83 |
|
| 3 | 4 | 3 | 4 | 2 | 4 | 0.83 |
|
|
| ||||||
I-CVI: item-level content validity; S-CVI: scale-level content validity; NA: not applicable.
Descriptive characteristics of the study population
| Inter-item and inter-rater reliability (children) | Inter-item and inter-rater reliability (parents) | Concurrent validity | Inter-item reliability (independent cohort) | ||||
|---|---|---|---|---|---|---|---|
| PAQ-C (n = 192) | PAQ-A (n = 94) | PAQ-C (n = 192) | PAQ-A (n = 94) | PAQ-A (n = 44) | PAQ-C (n = 26) | PAQ-A (n = 21) | |
| Age, years | 8.9 ± 1.7*** | 13.6 ± 1.4 | 14.2 ± 1.8 | 9.1 ± 2.0*** | 13.2 ± 2.1 | ||
| Gender | |||||||
| Boys, n (%) | 91 (47.4) | 42 (44.7) | - | - | 26 (59.0) | 12 (46.2) | 14 (66.7) |
| Girls, n (%) | 101 (52.6) | 52 (55.3) | - | - | 18 (41.0) | 14 (53.8) | 7 (33.3) |
| Height, cm | 138.1 ± 11.3*** | 165.0 ± 9.3 | - | - | 164.3 ± 10.5 | 138.2 ± 13.4*** | 159.2 ± 15.1 |
| Weight, kg | 32.1 ± 8.5*** | 54.6 ± 14.7 | - | - | 77.2 ± 26.4 | 38.2 ± 17.3*** | 63.6 ± 26.5 |
| BMI, kg/m2 | 16.5 ± 2.7*** | 19.9 ± 4.1 | - | - | 28.2 ± 8.1 | 19.1 ± 5.9** | 24.9 ± 8.5 |
| Q1 | 1.50 ± 0.25*** | 1.35 ± 0.22 | 1.41 ± 0.21 | 1.30 ± 0.17 | 1.26 ± 0.19 | 1.38 ± 0.16* | 1.27 ± 0.12 |
| Q2 | 4.53 ± 0.72 | 4.59 ± 0.78 | 4.43 ± 0.76 | 4.50 ± 0.84 | 4.32 ± 1.13 | 4.58 ± 0.64 | 4.14 ± 1.11 |
| Q3 | 3.94 ± 1.01 | NA | 3.90 ± 0.94 | NA | NA | 3.89 ± 0.91 | NA |
| Q4 | 3.60 ± 1.21*** | 2.24 ± 1.01 | 3.53 ± 1.13 | 2.21 ± 0.97 | 2.34 ± 0.98 | 3.85 ± 1.29*** | 2.38 ± 1.16 |
| Q5 | 2.49 ± 1.22 | 2.28 ± 1.39 | 2.42 ± 1.19 | 2.24 ± 1.33 | 1.95 ± 1.36 | 2.23 ± 1.27 | 2.19 ± 1.47 |
| Q6 | 2.55 ± 1.09 | 2.38 ± 1.09 | 2.49 ± 1.05 | 2.38 ± 1.09 | 2.25 ± 1.22 | 2.39 ± 1.06 | 2.29 ± 1.06 |
| Q7 | 2.79 ± 0.89** | 2.46 ± 1.02 | 2.71 ± 0.87 | 2.50 ± 0.95 | 2.09 ± 1.20 | 2.50 ± 1.14 | 2.24 ± 1.04 |
| Q8 | 2.95 ± 0.97 | 2.93 ± 0.96 | 2.87 ± 0.86 | 2.80 ± 0.95 | 2.55 ± 1.32 | 2.69 ± 0.97 | 2.76 ± 1.04 |
| Q9 | 3.12 ± 0.91*** | 2.71 ± 0.81 | 3.01 ± 0.88 | 2.65 ± 0.79 | 2.24 ± 0.85 | 2.93 ± 0.82 | 2.46 ± 0.73 |
| Total mean PAQ | 3.05 ± 0.89*** | 2.62 ± 0.92 | 2.97 ± 0.89 | 2.57 ± 0.90 | 2.36 ± 0.74 | 2.94 ± 0.57** | 2.47 ± 0.69 |
NA: not applicable. All values are presented as mean ± SD, unless otherwise indicated. Significant differences were detected between PAQ-C and PAQ-A filled in by children and adolescents using the independent samples t test: *P < 0.05, **P ≤ 0.01 and ***P ≤ 0.001.
Inter-rater reliability for the Dutch PAQ-C and PAQ-A
| PAQ-C (n = 192) | PAQ-A (n = 94) | |||
|---|---|---|---|---|
| Observed agreement (%) | Weighted κ (95% CI) | Observed agreement (%) | Weighted κ (95% CI) | |
|
| 59.9 | 0.50 (0.41-0.60) | 77.7 | 0.67 (0.54-0.81) |
|
| 71.4 | 0.48 (0.37-0.59) | 73.4 | 0.53 (0.33-0.72) |
|
| 74.0 | 0.64 (0.55-0.73) | NA | NA |
|
| 71.9 | 0.68 (0.60-0.77) | 64.9 | 0.60 (0.46-0.73) |
|
| 67.7 | 0.63 (0.54-0.71) | 69.2 | 0.61 (0.47-0.76) |
|
| 71.9 | 0.69 (0.62-0.77) | 71. | 0.68 (0.53-0.79) |
|
| 69.8 | 0.56 (0.46-0.67) | 57.5 | 0.51 (0.38-0.65) |
|
| 72.4 | 0.65 (0.56-0.74) | 70.2 | 0.63 (0.51-0.76) |
|
| 65.6 | 0.64 (0.55-0.72) | 51.0 | 0.51 (0.38-0.64) |
|
| 65.6 | 0.60 (0.52-0.67) | 70.2 | 0.64 (0.51-0.77) |
95% CI: 95% Confidence Interval; NA: not applicable.
Concurrent validity of the PAQ-A
| VO2peak | |
|---|---|
|
| -0.012 |
|
| 0.438** |
|
| NA |
|
| 0.010 |
|
| 0.052 |
|
| 0.550*** |
|
| 0.608*** |
|
| 0.426** |
|
| 0.412* |
|
|
|
NA: not applicable. Spearman correlation coefficients (rs corrected for age, gender, height and weight) of PAQ-A with corresponding exercise test measures of VO2 peak. *P < 0.05; **P < 0.01; ***P < 0.001.